Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma
同时靶向程序性死亡-1 (PD-1) 和 CD137 可提高人类 BRAFV600 突变黑色素瘤小鼠模型的放射治疗效果
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-016-1843-4
Paula Kroon, Jules Gadiot, Marlies Peeters, Alessia Gasparini, Marcel A Deken, Hideo Yagita, Marcel Verheij, Jannie Borst, Christian U Blank, Inge Verbrugge
